latest news releases from the newsroom
Cyclacel Announces Phase 1 Data Published Elucidating Pharmacodynamics & Mechanism of Action of Seliciclib in Nasopharyngeal Cancer
BERKELEY HEIGHTS, N.J., March 5, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced publication of an investigator-sponsored Phase 1 study reporting pharmacodynamic effects of seliciclib, an orally-administered cell cycle modulator, in treatment-naive patients with undifferentiated nasopharyngeal cancer. The data were published in the February 2009 issue of the journal Clinical Cancer Research. The study was led by Boon-Cher Goh, MD and colleagues at National University Hospital, Singapore. Seliciclib, Cyclacel's orally available cyclin dependent kinase (CDK) inhibitor, is currently being evaluated in two randomized Phase 2 trials in patients with previously treated nasopharyngeal and non-small cell lung cancer.
New Independent Market Studies Reveal Growing Importance of Real-Time Data Integration Platforms
REDWOOD CITY, Calif., March 5, 2009 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA), the leading independent provider of data integration software and services, today announces the availability of two independent third-party research reports that validate the increasing need for and accelerating uptake of comprehensive data integration platforms delivering real-time, data integration and data services. The reports, from Datamonitor and Ovum, together underscore the data imperatives that inform today's key business processes - from customer acquisition and service to compliance - and the business opportunities engendered by faster, richer, more accurate data.
The Children's Place, Inc.
The Children's Place Retail Stores, Inc. Reports February Sales
SECAUCUS, N.J., March 5, 2009 (GLOBE NEWSWIRE) -- The Children's Place Retail Stores, Inc. (Nasdaq:PLCE) today announced net sales of $110.4 million for the four-week period ended February 28, 2009, a 1% decrease compared to net sales of $111.4 million for the four-week period ended March 1, 2008.